Immune system: our new fingerprint

In recent years, a considerable number of melanoma patients have shown great tumour regression when treated with immunotherapy agents. However, there is still a long way to go, when it comes to effectively select the patients that will actually benefit from these.

My PhD project at Lund University, focuses on understanding further the dynamics between the immune system and melanoma tumours. Are you interested in finding out why this is needed to make sure each patient receives an ideal treatment?

Check out my video!

 

Rita Cabrita, ESR11, Lund University